In monitoring anti-D during pregnancy, a fourfold rise in titer is considered significant.

Master the CAMLPR Transfusion Test with interactive questions and detailed explanations. Boost your knowledge and ensure you're exam-ready with comprehensive study resources!

In monitoring anti-D in pregnancy, you interpret changes by looking at both the antibody level and the fetal status. A fourfold rise in titer is a real increase beyond normal lab variation, and when this rise is paired with an increase in the fetal status score, it indicates that the antibody-mediated process is impacting the fetus. The combination of a substantial rise in maternal antibody and a worsening fetal score provides stronger evidence of clinically meaningful alloimmune activity and prompts closer monitoring or intervention. That’s why the best choice is the one that says yes, because the titer has increased fourfold and the score has increased. The other options downplay the importance of a real titer rise or ignore the corroborating fetal status, which isn’t consistent with how these findings are used together in practice.